- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Rhythm Pharmaceuticals Stock (NASDAQ:RYTM), Quotes and News Summary
Rhythm Pharmaceuticals Stock (NASDAQ: RYTM)
| Day Range23.68 - 25.24 | 52 Wk Range3.04 - 30.98 | Open / Close24 / 24.84 | Float / Outstanding39.3M / 55.7M |
| Vol / Avg.1M / 2.4M | Mkt Cap1.4B | P/E- | 50d Avg. Price21.79 |
| Div / Yield- | Payout Ratio- | Total Float39.3M | EPS-0.89 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-01 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.950 | -0.890 | 0.0600 | ||||
| REV | 2.580M | 9.066M | 6.486M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Rhythm Pharmaceuticals Questions & Answers
You can purchase shares of Rhythm Pharmaceuticals (NASDAQ: RYTM) through any online brokerage.
Other companies in Rhythm Pharmaceuticals’s space includes: Zentalis Pharmaceuticals (NASDAQ:ZNTL), Chinook Therapeutics (NASDAQ:KDNY), Syndax Pharmaceuticals (NASDAQ:SNDX), FibroGen (NASDAQ:FGEN) and Arcutis Biotherapeutics (NASDAQ:ARQT).
The latest price target for Rhythm Pharmaceuticals (NASDAQ: RYTM) was reported by Goldman Sachs on Thursday, September 8, 2022. The analyst firm set a price target for 31.00 expecting RYTM to rise to within 12 months (a possible 24.80% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Rhythm Pharmaceuticals (NASDAQ: RYTM) is $24.84 last updated Today at October 4, 2022, 8:00 PM UTC.
There are no upcoming dividends for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 1, 2022.
There is no upcoming split for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.